—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Protagonist Therapeutics Inc (PTGX) — Quality & forensics

As of 2026-10-12 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.

The Closelooknet module scores

60 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

98.40 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

4/8 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-6.77 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the PTGX chart & overview · the earnings record

FAQ · from the current data · as of 2026-10-12

Quick answers

What is Protagonist Therapeutics Inc's Closelooknet quality reading?

The composite reads 60/100 across 7 modules, as of 2026-10-12: valuation 10, quality 60, growth 70, balance sheet 98, cash quality 62, capital allocation 31, momentum 84. Closelooknet scores are research diary readings, not ratings or investment advice.

What is Protagonist Therapeutics Inc's Altman Z-Score?

98.40, which sits in the safe zone (above 2.99) as of 2026-10-12. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Protagonist Therapeutics Inc's Piotroski F-Score?

4 of 8, as of 2026-10-12. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Protagonist Therapeutics Inc's Beneish M-Score indicate?

-6.77 — below the −1.78 manipulation-risk threshold, as of 2026-10-12. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.